一个患有三体 18 的儿童患有川崎病,接受初始组合疗法治疗,包括循环氨酸
Yasuyuki Sahara1, Naomi Yagi1, Yoshitaka Watanabe1
1Children's Medical Center, Showa Medical University Northern Yokohama Hospital, Yokohama-shi, Kanagawa, Japan.
Case reports in pediatrics
|February 23, 2026
概括
本案例研究报告了卡瓦萨基病在患有三症18的患者中的第一个病例. 包括环素在内的治疗是成功的,耐受性很好,对这种罕见的组合显示出有利的结果.
科学领域:
- 儿童心脏病学 儿童心脏病学
- 遗传学 是一个遗传学.
- 免疫学 免疫学 免疫学
背景情况:
- 川崎病是一种常见的儿科炎症状况.
- 三胞体18 (爱德华兹综合征) 是一种染色体疾病,在历史上预后不佳,但生存率有所改善.
- 对于婴儿期以后的三症18患者存在有限的数据,并且之前没有报告过三症18的Kawasaki病例.
研究的目的:
- 报告第一个患有18型三症的Kawasaki病例.
- 描述这种罕见的并发症的成功管理和临床过程.
- 在复杂的儿科病例中强调当前治疗指南的安全性和有效性.
主要方法:
- 一个3岁至11个月的女性患有三症 18 呈现出与川崎病相一致的症状.
- 治疗遵循日本的指导方针,包括静脉注射免疫球蛋白,阿司匹林和口服环素,由于预测的耐药性.
- 在治疗后监测临床过程和冠状动脉状况.
主要成果:
- 该患者满足了川崎病的六个诊断标准中的五个.
- 静脉注射免疫球蛋白,阿司匹林和环素的治疗导致了无并发症或不良事件的分泌.
- 在急性或随访评估期间没有观察到冠状动脉异常.
结论:
- 川崎病可以发生在患有三症18的患者中.
- 目前的日本治疗指导方针,包括环素,是安全有效的管理Kawasaki病在三症18患者.
- 对于改善长期结果至关重要的是进一步研究18型三症儿科疾病的自然史和治疗疗效.
相关概念视频
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
303
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
303
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
276
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
276
01:28Pulmonary Tuberculosis V
669
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
669
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
353
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
353
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
591
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
591